Irland - engelska - HPRA (Health Products Regulatory Authority)

ucb pharma limited - hydrocortisone sodium succinate - buccal tablet - 2.5 milligram

Irland - engelska - HPRA (Health Products Regulatory Authority)

ucb pharma limited - glyceryl trinitrate - transdermal patch - 10 mg/day

Irland - engelska - HPRA (Health Products Regulatory Authority)

ucb pharma limited - glyceryl trinitrate - transdermal patch - 5 mg/day

Irland - engelska - HPRA (Health Products Regulatory Authority)

ucb pharma limited - isosorbide dinitrate - concentrate for solution for injection or infusion - 1mg/ml - vasodilators used in cardiac diseases - it is indicated in the treatment of unresponsive left ventricular failure secondary to acute myocardial infarction, unresponsive left ventricular failure of various aetiology and severe or unstable angina pectoris. and during percutaneous transluminal coronary angioplasty to facilitate prolongation of balloon inflation and to prevent or relieve coronary spasm.

Irland - engelska - HPRA (Health Products Regulatory Authority)

ucb pharma limited - isosorbide dinitrate - solution for infusion - 0.05 %w/v

Irland - engelska - HPRA (Health Products Regulatory Authority)

ucb pharma limited - acetylcysteine - concentrate for soln for inf - 200 mg/ml

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - levetiracetam, quantity: 750 mg - tablet, film coated - excipient ingredients: macrogol 6000; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - keppra (film coated tablets and oral solution) is indicated for - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. - add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme), and - add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige). keppra concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ucb pharma ltd - ethinylestradiol - oral tablet - 1mg

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - olsalazine sodium -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - rotigotine -